Q4 2025 Management View Daniel Perez, Co-Founder, CEO & Director, described 2025 as "an exceptional year that demonstrated the power of our vision to automate health care delivery through technology." ...

A 12-week, 177-participant trial of Hinge Health’s at-home digital program for chronic pain relief significantly reduced users’ lower back pain, disability and interest in surgery. The study, led by ...

San Francisco-based Hinge Health has completed a randomized control trial of its digital care program for chronic knee pain. Results were promising, with users of the digital platform outperforming ...

When digital musculoskeletal company Hinge Health launched about a decade ago, it primarily targeted employers directly. However, in recent years, it has expanded its health plan partnerships and is ...

Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today’s fragmented healthcare system leaves many people unsure how to pursue ...

(RTTNews) - Hinge Health, Inc. (HNGE) on Wednesday announced that its board of directors has authorized a $250 million share repurchase program. "During the first three quarters of 2025, we generated ...

Good afternoon, and welcome to Hinge Health's Fourth Quarter and Full Year 2025 Earnings Call. I'm Bianca Buck, Head of Investor Relations. With me on the call are Daniel Perez, our Co-Founder and CEO ...

SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (HNGE) today announced that its board of directors has authorized a $250 million share repurchase program. “During the first three quarters of 2025, ...

Collaboration Will Promote Best-in-Class Menopause Care for Employers and Members SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health and Midi Health announced a partnership today to address the significant ...